Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over and over how this notion has not been the case. Medtronic Inc.…
Douglas A. McIntyre Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin of Boston Scientific Corp. (NYSE: BSX) has somehow managed to hang on…
According to Reuters, Toyota (TM) cut production and Nissan was downbeat about its prospects. Reuters reports that if a new CEO at Yahoo! (YHOO) wants to be well-regarded by shareholders, he or…
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study…
According to Reuters, policy makers around the world are trying to deal with the fact that the economy is moving into a deep recession. Reuters writes that Google (GOOG) exceeded forecasts and…
There is one critical aspect to the stock market that pertains to American International Group (NYSE: AIG) which has been given less coverage because of the media’s focus on the turmoil in…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. Below…
With the trading year almost half over and results from the first quarter out, 24/7 Wall St. has created the latest installment of its Ten Worst Managed Companies In America list. This…
These are ten of the analyst calls we are focusing on this morning: Central Garden (NASDAQ: CENT) raised to Buy at Piper Jaffray. China Sunergy (NASDAQ: CSUN) raised to Hold at Jefferies.…
Salient Surgical Technologies, Inc. has filed to come public via an initial public offering and has applied to trade on the NASDAQ under the ticker "SLNT." The company lists that it will…
Douglas A. McIntyre These are some of the top analyst calls this morning: Alcoa (NYSE: AA) cut to Market Perform at FBR. Dr. Reddy’s (NYSE: RDY) cut to Hold at Citigroup. Freeport-McMoRan (NYSE: FCX) cut…
Medtronic, Inc. (NYSE: MDT) has just announced that it has received formal approval from the FDA to market its Endeavor Zotarolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. This…
Below is the short interest for major companies traded on the NYSE and changes from October 15, 2007 to the most current date, October 31, 2007. Company …
Medtronic (MDT) is warning doctors and patients to look at the company’s latest "defibrillator models because it was prone to a defect that has caused malfunctions in hundreds of patients and may…
Douglas A. McIntyre According to Reuters, Citigroup (C) and other large banksare planning to create a roughly $80 billion fund to buy ailing mortgage securities and other assets. Reuters writes that Medtronic (MDT) is suspending…